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Assembly of a transcriptional and post-translational molecular interaction network in B cells, the
human B-cell interactome (HBCI), reveals a hierarchical, transcriptional control module, where
MYB and FOXM1 act as synergistic master regulators of proliferation in the germinal center (GC).
Eighty percent of genes jointly regulated by these transcription factors are activated in the GC,
including those encoding proteins in a complex regulating DNA pre-replication, replication, and
mitosis. These results indicate that the HBCI analysis can be used for the identiﬁcation of
determinants of major human cell phenotypes and provides a paradigm of general applicability to
normal and pathologic tissues.
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Introduction
Comprehensive repertoires of molecular interactions
(interactomes) are becoming increasingly useful in the
dissection of biological processes because they provide an
integrated view of regulatory programs in the cell (Rhodes
et al, 2005). However, their ability to elucidate novel
mechanisms of regulation of physiologic and pathologic
human phenotypes is still largely undeveloped. For instance,
sophisticated analyses of protein–protein (Goh et al, 2007;
Lage et al, 2007; Karni et al, 2009; Wu et al, 2009),
transcriptional (Ergun et al, 2007), and literature-based
(Rzhetsky et al, 2004) interactomes were recently successful
in recapitulating previously known disease-related genes.
However, novel predictions lacked speciﬁcity and were not
validated. A notable exception is constituted by recent models
of obesity (Yang et al, 2009), whose predictions were
conﬁrmed in vivo. These methods, however, require trans-
genic and knockout mouse models and cannot be readily
extended to human phenotypes. Regulatory networks in
multicellular organisms are also exquisitely cell-context
speciﬁc. Yet, most interactomes lack context-speciﬁcity be-
cause their interactions are supported by ex vivo assays (Rual
et al, 2005) or literature data assembled from a diverse mix of
cellularphenotypes.Finally,exceptforafewexamplesinyeast
(Yeger-Lotem et al, 2004; Yu et al, 2006) and for literature-
based attempts (Bader et al, 2003; Rzhetsky et al, 2004),
available interactomes represent individual layers, such as
transcriptional regulation (Rhodes et al, 2005; Palomero et al,
2006; Ergun et al, 2007) or protein complexes (Goh et al, 2007;
Lage et al, 2007) rather than an integrated view of regulatory
processes.
Here, we show how cell-context-speciﬁc interactomes can
be efﬁciently and accurately assembled from high-throughput
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assays, etc) using an evidence integration approach by
assembling a human B-cell interactome (HBCI). Furthermore,
we show that its analysis elucidates both master regulator
(MR) genes individually or synergistically controlling speciﬁc
cellular processes and transcriptional regulation of proteins in
large complexes, whose availability must be regulated in
context-dependent manner. The latter is a poorly understood
process, as transcriptional networks and protein–protein
interaction (PPI) networks are usually studied in isolation. It
speciﬁcally highlights the advantage of an integrated regula-
tory model, where transcriptional and post-translational
interactions may be interrogated at once to discover novel
complexes. Speciﬁcally, the HBCI was interrogated to discover
MRs of key genetic programs in the germinal center (GC)
reaction of antigen-mediated immune response, that is, genes
that are required for normal progression through the GC, as
well as novel physical interactions between the pre-replication
complex and mitotic-control proteins. GCs are structures
where antigen-stimulated B cells highly proliferate, undergo
somatic hypermutation of immunoglobulin genes, and are
selected based on the production of high-afﬁnity antibodies.
GC B cells (centroblasts) derive from naive B cells,fromwhich
they differ for the activation of genetic programs controlling
cell proliferation, DNA metabolism, and pro-apoptotic pro-
grams and for the repression of anti-apoptotic, cell-cycle
arrest, DNA repair, and signal transduction programs from
cytokines and chemokines (Klein et al, 2003). A few
transcriptional regulators (BACH2, BCL6, IRF8, POU2AF1,
andSPIB) necessary for GC formation (Klein andDalla-Favera,
2008) were identiﬁed by genetic and biochemical analyses.
However, an unbiased and comprehensive repertoire of GC
MRsisnotavailable,andmethods for theidentiﬁcationof MRs
of human phenotypes are still lacking.
Results
The human B-cell interactome
To construct an integrated, cell-context speciﬁc, human
interactome, we reverse-engineered transcriptional and
post-translational interactions in mature human B cells from
a large and phenotypically diverse collection of 254 B-cell
GEPs representing 24 distinct phenotypes derived from
normal and malignant mature B cells (Lefebvre et al, 2007).
Reverse engineering was performed using validated algo-
rithms, such as ARACNe (transcriptional) (Basso et al, 2005;
Margolin et al, 2006; Palomero et al, 2006) and MINDy (post-
translational) (Wang et al, 2006, 2009a,b; Mani et al, 2008).
An established Bayesian evidence integration algorithm
(Jansen et al, 2003) further integrated evidence from experi-
mental assays, databases, and literature data mining, ﬁltered
by context-speciﬁc criteria (full details of the method,
performance analysis, and comparison with other methods
can be found in Supplementary Figures S1–S3). The HBCI
comprises B66000 B-cell-speciﬁc molecular interactions
(Supplementary Table I), including both PPIs, representing
direct physical interactions and indirect ones within the same
complex, and direct protein–DNA interactions (Lefebvre et al,
2007).
MAster regulator INference algorithm
To discover MRs of the GC reaction, we interrogated the HBCI
using a new algorithm, MAster Regulator INference algorithm
(MARINa), designed to infer transcription factors (TFs)
controlling the transition between the two phenotypes, A
and B, and the maintenance of the latter phenotype.
Expression at the mRNA level is often a poor predictor of a
TF’s regulatory activity and an even worst predictor of its
biological relevance in regulating phenotype-speciﬁc pro-
grams. To obviate this problem, MARINa infers TF activity
from the global transcriptional activation of its regulon (i.e. its
activated and repressed targets) and its biological relevance by
TF-regulonoverlapwithphenotype-speciﬁcprograms.Indeed,
we reasoned that if the naive-B-cell- centroblast transition is
supported by the activation (or repression) of speciﬁc TFs,
then their targets should be among the most-differentially
expressed genes between the two cellular phenotypes, with
activated and repressed targets at the opposite end of the
expression range. MARINa requires a regulatory model (the
HBCI in this case) and a GEP signature of the phenotype
transition (i.e. all genes ranked by their differential expression
in two phenotypes). Here, the signature, SGC, was obtained by
t-test analysis of GC centroblasts versus naive B-cells
GEPs. MRs of GC development were then inferred in four
steps. First, each TF was associated with a positive and a
negative regulon, using its activated and repressed targets in
the HBCI, respectively. Second, we computed for each TF its
activitybygenesetenrichmentanalysis(GSEA)(Subramanian
et al, 2005) of the SGC signature in TF-regulon genes (SGC
enrichment) and its biological relevance by the overall
contribution of TF-regulon genes to GC-speciﬁc programs
measured with the differentially expressed target odds
ratio (DETOR) score (see Materials and methods). Third,
MARINa corrected for TF-regulon overlap, a frequent event in
mammalian networks (Margolin et al, 2009; Carro et al, 2010),
leading to false-positive MR inference. Indeed, if the
regulons of an MR and of a non-MR gene overlapped
signiﬁcantly, then the latter would also be SGC enriched,
yielding a false positive. These TFs (shadow regulators or SRs)
can be identiﬁed and removed by determining whether their
enrichment is signiﬁcantly reduced when shared targets are
disregarded (see Supplementary information). We also identi-
ﬁed synergistic TF pairs, whose common targets are more SGC
enriched than their individual regulons (see Supplementary
information). Finally, the GC-MRs are deﬁned as the non-SRs,
thatisenrichedTFsthatarenotashadowofanyother,andSRs
that are synergistic with a non-SR (see Supplementary
information).
When applied to 194 TFs displaying X20 targets in the
HBCI, MARINa identiﬁed 41 candidate MRs, of which 26
were GC activated and 15 were GC repressed (Po10
 3,
Supplementary Figure S4). Results of the different steps of
MARINa can be found in Supplementary Tables II–IV. Note
that inference of the TF regulons from a subset of the data that
did not include samples used to deﬁne the SGC signature
identiﬁed virtually the same MR set, as shown in the
Supplementary Figures S5 and S6. This conﬁrms that use of
the SGC-related samples in the network inference analysis does
not lead to data overﬁtting in the inference of MRs.
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MARINa-inferred MRs included established GC MRs (Table I;
see review Klein and Dalla-Favera, 2008). Of ﬁve such genes,
three (BCL6, POU2AF1, and SPIB) were directly identiﬁed by
MARINa, one (IRF8) was borderline signiﬁcant (Pp0.01), and
one (BACH2) could not be analyzed because it was not
represented in the GEP data. It should be noted here that
POU2AF1 is not a TF, as it does not directly bind DNA, but
rather a transcriptional regulator. In this case, it was included
only to illustrate that it could be recovered accurately by the
analysis. Ultimately, all transcriptional regulators may be
analyzed by the same approach if desired. MARINa also
identiﬁed other TFs reported to have a function in GCs, such
as LMO2 (Natkunam et al, 2007) (GC activated), IRF4 (Klein
and Dalla-Favera, 2008), BHLHE40 (Seimiya et al, 2004),
and JUNB (Ci et al, 2009) (GC repressed), suggesting that
the analysis recapitulates known regulators of GC develop-
ment. MARINa-inferred activity was generally qualitatively
(i.e. activated versus repressed) but not quantitatively
consistent with TF differential expression (Supplementary
Figure S4). However, not all the MRs identiﬁed by the
method could have been identiﬁed by GEP analysis alone
(Supplementary Figure S7).
MARINa identiﬁed 23 candidate GC-MRs controlling large
GC-speciﬁc programs (nX100 targets) including several new
ones (Figure 1). MYB was the most signiﬁcant GC-activated
MR, with 464% of its targets differentially expressed in GCs
(FDRp0.05 by t-test). Interestingly, regulon analysis (steps
1–2) suggested strong GC activation of the MYC-regulon genes
(Pp10
 4). However, MYC was identiﬁed and removed as an
SR (Supplementary Table III), consistent with the observation
that its expression is low in the majority of GC B cells (Klein
et al, 2003). FOXM1 provided the largest contribution to this
result, by regulating X35% of the MYC-regulon genes that
were GC activated. This suggests that FOXM1 may have a
critical function in GC formation by regulating speciﬁc MYC
targets necessary for rapid growth and proliferation. Further
analysis of candidate synergistic TF pairs by MARINa revealed
that FOXM1 appearedin 7 of the 10 pairsthat regulate largeGC
programs (Supplementary Table IV), speciﬁcally co-regulating
150 MYB targets, 121 of which (81%) were differentially
expressed in GCs (FDRp0.05 by t-test, Figure 2). Taken
together, these results suggest that MYB and FOXM1 are
synergisticMRsofproliferationintheGC,asalsosupportedby
the GC-speciﬁc downregulation of mir150 (Basso et al, 2009),
a tight repressor of MYB (Xiao et al, 2007), and the fact that
MYB protein is expressed in centroblasts despite low MYB
mRNA levels (Supplementary Figure S8), suggesting speciﬁc
stabilization.
MYB and FOXM1 form a feed-forward loop
We ﬁrst tested whether MYB and FOXM1 may regulate each
other as predicted in the HBCI. Synergistic TFs often
participate in feed-forward loops (Palomero et al, 2006; Carro
et al, 2010), increasing the resilience of regulatory networks to
transient perturbations by the maintenance of the cell in a
phenotype that could be affected by the ﬂuctuation in the
levels of either TFalone. MYB and FOXM1 were silenced in the
ST486 Burkitt’s lymphoma line, representative of transformed
GC B cells, by lentiviral-mediated transduction of MYB/
FOXM1-speciﬁc and control shRNAs (Figure 3). Decrease of
endogenous MYB and FOXM1 protein levels in speciﬁc versus
control shRNA-transduced samples was conﬁrmed by western
blot (Figure 3A and B). qPCR assays conﬁrmed mRNA-level
reduction of both TFs at 24h (Figure 3C), persisting at 48 and
72h(datanotshown).MYBmRNAandproteinlevelswerenot
affected by FOXM1 silencing, whereas FOXM1 mRNA and
protein levels were both reduced in a time-dependent manner
after MYB silencing (Figure 3A–C). These results suggest that
MYB is a transcriptional activator of FOXM1. Quantitative
chromatin IP (qChIP) assays showed that MYB binds in vivo to
the FOXM1 promoter (Figure 3D). Together, these ﬁndings
suggest that MYB and FOXM1 form a feed-forward loop,
involved in the synergistic activation of a large subset of GC-
speciﬁc genes.
MYB and FOXM1 silencing affects the expression
of their common predicted targets and other MRs
To test whether common MYB/FOXM1 targets and other MRs
were affected by silencing of either TF, Affymetrix HG-U95A
GeneChip GEP were obtained in triplicate from ST486 cells
after transduction with FOXM1, MYB, and control shRNA. To
eliminate indirect regulation effects, a 24h time point was
selected with a 25% lower viral load for MYB shRNA than for
the time-course experiment (Figure 3A), ensuring that FOXM1
protein levels were not yet affected by MYB silencing
(Supplementary Figure S9). Silencing was conﬁrmed by
western blot and qPCR (Supplementary Figure S9). GSEA
analysis of predicted MYB/FOXM1 targets against differen-
tially expressed genes after silencing conﬁrmed that positive
MYB/FOXM1-regulon targets were downregulated by silen-
cing either TF (Po10
 4 in both cases, Supplementary Figure
S10). Although, the negative regulon was too small for GSEA
analysis, having only 19 genes, ﬁve of these were signiﬁcantly
upregulated after FOXM1 or MYB silencing. Accordingly,
qChIP assays for six inferred MYB/FOXM1 targets (AURKA,
BUBR1, CCNB2, FANCI, MCM3, and PTTG1), whose mRNA
levels decreased signiﬁcantly after silencing of either TF
(Supplementary Table V) conﬁrmed that both TFs bind to their
promoters (Figure 3E). GEP analysis, conﬁrmed by qPCR,
identiﬁed TFs downregulated after MYB/FOXM1 silencing,
including NFYB, E2F5, and E2F1, three of the most signiﬁcant
Table I Known MRs of germinal center formation and maintenance and
MARINa inference
Master regulator MARINa-inferred TF activity MARINa P-value
BACH2 Not tested NA
BCL6 Activated o10
 4
IRF8 Activated 0.01
POU2AF1 Activated o10
 4
SPIB Repressed 4 10
 4
A master regulator is either ‘activated’ or ‘repressed’, that is showing,
respectively, increased or decreased activity in centroblasts compared with
naive B cells. If activated, an MR shows more activation and/or repression of its
targets, whereasif repressed, an MRwill showless activation and/or repression.
Master regulators of germinal center proliferation
C Lefebvre et al
& 2010 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2010 3MRs after MYB (Supplementary Figure S11), whereas qChIP
assays conﬁrmed binding of both FOXM1 and MYB to their
promoters (Figure 3E). Taken together, these data suggest a
highly connected, hierarchical transcriptional control module
(TCM), with MYB and FOXM1 as synergistic top-level MRs
(Figure 4).
Figure 1 GC-MRs regulating 4100 targets. Left side of the plot shows the distribution of the positively (red) and negatively (blue) correlated targets of the MR on the
gene list ranked by differential mRNA expression in centroblast compared with naive samples. The right side of the plot shows a heatmap of the mRNA expression level
of the MRs in naive (N) and centroblast (CB) samples. Source data is available for this ﬁgure at www.nature.com/msb.
Figure 2 FOXM1/MYB network. (A) FOXM1/MYB subnetwork from the HBCI. (B) Distribution of the MYB/FOXM1 regulon against a list of genes ranked by their
differentially expression in centroblast compared with naive B cells. Source data is available for this ﬁgure at www.nature.com/msb.
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reduce cell proliferation
To gain insight into the biological signiﬁcance of the programs
controlled by the MYB/FOXM1 pair, we performed Gene
Ontology (GO) (Ashburner et al, 2000) term enrichment
analysisoftheircommontargetgenes,whichshowedthatthey
regulate cell-cycle dependent programs, including replication,
replication initiation, cell proliferation, and mitosis (Supple-
mentary Table VI). We thus investigated the physiological
changesinducedbyFOXM1andMYBsilencing.BrdUassaysat
24h in ST486 cells showed a 15 and 30% decrease in
proliferating cells, after FOXM1 and MYB silencing, respec-
tively (Figure 5A), and a similar decrease at 48 and 72h (data
not shown). Annexin V and propidium iodide staining at the
same time points showed gradual increase of apoptotic cells
reaching 30 and 40% (Figure 5B) and dead cells reaching 67 and
77% (data not shown) at 72h after FOXM1 and MYB silencing,
respectively. At that time point, MYB protein was 90% silenced,
suggesting that loss of MYB protein induces apoptosis both in a
FOXM1-dependent and a FOXM1-independent way. These
results indicate that MYB and FOXM1 are necessary for viability
and rapid proliferation of GC-related B cells.
Pre-replication and mitosis-related targets of MYB
and FOXM1 are involved in a protein complex
To gain more insight into the control of GC-proliferation
phenotype by MYB and FOXM1, we further examined speciﬁc
targets involved in the coordinated formation of a large and
Figure 3 MYB directly regulates the transcription of FOXM1. (A) Western blot analysis of ST486 total cell lysates obtained at 24, 48, and 72h after lentiviral-mediated
transduction of control, FOXM1, or MYB shRNA. Viral load was set for complete silencing of FOXM1 at 24h but only partial (450%) silencing of MYB, as complete
silencing induced 480% apoptosis at 48h (data from previous experiment). GAPDH was used as a loading control. (B) Percentage of FOXM1 protein level on MYB
silencing were calculated by densitometric analysis (in ImageJ) and normalized to GAPDH protein level. (C) qPCR analysis showing the mRNA expression level of
FOXM1 and MYB at 24h. Similar results were observed at 48 and 72h (data not shown). (D) qChIP with control IgG or anti-MYB antibody at FOXM1-binding site. Data
shown in (A, C) are representative of one of three independent experiments. Error bars were calculated (C) from samples run in duplicate or (D) from two sets of three
independent real-time PCR reactions. (E) qChIP with control IgG, anti-FOXM1, and anti-MYB antibodies performed in the nuclear extract of ST486 cells. Samples from
two independent experiments were pooled together and real-time PCR reactions were run in duplicate. Error bars represent the standard error.
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type of analysis was not afforded by earlier approaches that
considered the transcriptional and post-translational interac-
tion layers in isolation and highlights a key novelty of such an
integrated regulatory model. Approximately half of MYB/
FOXM1 targets cluster within an HBCI-inferred protein
complex, which is poorly represented in existing protein–
protein interactomes (Rual et al, 2005). Surprisingly, these
proteins are virtually all members of only three biological
process categories in GO: replication initiation (Pp10
 6),
replication (Pp10
 19), and mitosis (Pp10
 32) (Supplemen-
tary Figure S12). For instance, the HBCI-inferred complex
included four of the six members of the replicative helicase
complex MCM2–7 (Ying and Gautier, 2005), suggesting that
missingproteins(MCM2and MCM5)may befalsenegativesin
the HBCI and that assembly of the replicative helicase in GCs
may be regulated by the MYB/FOXM1 module. This was
experimentally conﬁrmed since ﬁve (MCM3–7) out of the six
MCM genes (80%), and 58% of all pre-replication complex
(pre-RC) proteins were downregulated after MYB or FOXM1
silencing (Supplementary Figure S13). As pre-RC and mitotic
proteins have not been previously reported to physically
interact, we tested whether two mitotic kinases (BUBR1 and
AURKA) in the inferred complex physically interact with
MCM3, a core protein of the MCM2–7 replicative helicase,
chosen based on reagent availability. GEP, qPCR, and qChIP
assaysshowed that their mRNA level was affected by silencing
of either FOXM1 or MYB (Supplementary Figure S11A) and
that both TFs bind to their promoters (Figure 3E), conﬁrming
thattheyaredirecttargetsofFOXM1andMYB.BUBR1/MCM3,
AURKA/MCM3 interactions were conﬁrmed by endogenous
co-immunoprecipitation (co-IP) assays in Ramos (Figure 6A)
and ST486 Burkitt’s lymphoma lines (data not shown). Ramos
cells were included as their large size is optimal for confocal
microscopy analysis. The novel AURKA/BUBR1 interaction
was also conﬁrmed (data not shown). Co-IP assays of
homologues of these proteins in Xenopus extracts, which are
devoid of genomic DNA, conﬁrmed that these interactions are
not chromatin mediated (Figure 6B). Similar results were
obtained when the MCM complex was immunoprecipitated
with XMCM3 and XMCM6 antibodies (data not shown). These
experiments establish that MCM3/6-BUBR1 and MCM3/6-
AURKA interactions are either direct or protein mediated, as
predicted by the HBCI,but not DNAmediated. High-resolution
confocal imaging showed that these proteins are co-localized
either in the nucleus or perinuclearly (Figure 6C). Finally,
analysis of E-Map data (Collins et al, 2007) (see Supplemen-
tary information) showed a strong association between pre-RC
and mitotic control in yeast, suggesting that the interaction
between these proteins may be evolutionarily conserved
(Supplementary Tables VII–VIII; Supplementary Figure S14).
Discussion
In summary, these results document that coordinated analysis
of both transcriptional and post-translational interactions in
the HBCI can identify synergistic MRs of human phenotypes,
as well as provide insight on the functional regulatory role of
these proteins. Speciﬁcally, analysis of the MRs’ regulatory
targets led to the discovery of a large complex that includes
both the pre-RC and mitotic-control proteins and whose
functional role is narrowly deﬁned. This would not have been
possible if thetranscriptionaland post-translational regulation
layer had been independently analyzed. Indeed, biochemical
andfunctionalvalidationsuggeststhattheHBCIconstitutes an
informative and accurate model of regulation, providing a
useful framework to investigate normal B-cell biology and its
dysregulation in B-cell lymphomas, which derive from GC B
cells (Mani et al, 2008).
Figure 4 TCM showing GC-MRs controlled by MYB and FOXM1 and their targets. The ﬁgure describes the relationship between MYB and FOXM1 and three other
MRs downregulated after silencing the two TFs independently (see qPCR results in Supplementary Figure S11). We used hierarchical clustering to cluster the ﬁve MRs
according to their common targets. The distance between each MR was computed using their percentage of common targets and we used the ward agglomeration
method. Gene Ontology enrichment was computed for common MRs targets as well as speciﬁc targets of each MR.
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S15) shows that the regulatory programs controlled by the
MYB/FOXM1 TCM and by other MRs, including experimen-
tally validated ones are virtually non-overlapping. This
suggests that GCregulationis implemented bythe coordinated
activation and repression of several individual MRs and MR
modules, each one controlling speciﬁc GC-related programs,
and thus not individually sufﬁcient for GC formation. More-
over, the network reconstruction and MR identiﬁcation arenot
dependent on the inclusion of a speciﬁc subset of B-cell
samples (Supplementary information). Indeed, excluding 14
naive and centroblast samples or any 14 samples did not
signiﬁcantly affect the TCM inference (Supplementary Figures
S5 and S6).
The HBCI constitutes only an initial draft of human B-cell
regulatory networks. For instance, some interactions may be
missed (false negatives, FN) and some incorrect interactions
maybe included in the model (false positives, FP). In addition,
analysis of multivariate regulation is only in its infancy and
better models will be developed over the next few years. The
HBCI must thus be used with the full understanding of its
limitations but with the expectation that, as such models
improve over time, they will provide increasingly more
accurate model of cell-speciﬁc behavior. In this, evolutionary
constraints to achieve functional canalization (Waddington,
1959) help dramatically. For instance, as shown here and in
earlier work (Palomero et al, 2006; Margolin et al, 2009; Carro
etal,2010),thedominantuseoffeed-forwardloopstostabilize
and specialize TF regulation in human cells creates critical
redundancy that obviates FNs. Similarly, regulon size of TFs
associated with regulation of key function makesthese models
relatively insensitive to FPs as, statistically, activity can be
better estimated from large number of targets due to their
combinatorial regulation. It is also difﬁcult to evaluate the
accuracy of the network reconstruction with traditional
metrics, mainly because of the highly incomplete nature of
gold standard sets, both positive and negative. These metrics
can be effectively used to compare relative performance
between different approaches but not to estimate the absolute
FP and FN rates of the methods. Therefore, experimental
validation is the ultimate criterion to measure the method’s
precision. As shown, experimental validation conﬁrmed the
accuracyofthereverse-engineerednetworkandsuggestedthat
the use of such a model can capture important regulatory
processes such as cell proliferation.
Taken together, our data suggest that the assembly of
context-speciﬁc interactomes, such as the HBCI, coupled with
algorithms for their interrogation, such as MARINa, constitute
valuable resources in the elucidation of physiologic pheno-
types. In particular, the approach can be applied to any
phenotypic transition thus establishing a novel paradigm for
the study of context-speciﬁc cellular regulation.
Materials and methods
Differentially expressed target odds ratio
Results were classiﬁed using the DETOR score for differentially
expressed target odds ratio and computed as:
DETORTFi ¼ð GSLE
i =RSLE
i Þ

ðGSi=RSiÞ
where GSi
LE and RSi
LE are the number of genes before the leading edge
inGSEAforthegeneset(orregulon)andforthereference set,whereas
GSi and RSi are the sizes of the gene set and the reference set.
Cell lines and cell culture
ST486 and Ramos cells were maintained in Iscove’s modiﬁed
Dulbecco’s medium supplemented with 10% FBS and antibiotics.
293FT cells were maintained in Dulbecco’s minimum essential
medium supplemented with 10% FBS and antibiotics.
Figure 5 FOXM1 and MYB are required for cell proliferation and viability of
ST486 cells. (A) Proliferating ST486 cells were quantiﬁed by BrdU labeling of
cells transduced with control, FOXM1, or MYB shRNA, and collected at 24h.
Error bars represent standard error calculated from the samples run in triplicate.
(B) The percentage of apoptotic ST486 cells was assessed by Annexin V
stainingofcellstransducedwithcontrol,FOXM1,orMYBshRNAandcollectedat
24, 48, and 72h post-infection.
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Control shRNA (SHC002), FOXM1 shRNA (TRCN0000015546), or
MYB shRNA (TRCN0000040062) cloned into pLKO.1-puro lentiviral
vector was purchased from Sigma. To generate lentiviral particles, the
individual shRNA clones (2.8mg) were co-transfected with VSVG
envelope plasmid (280ng) and D8.9 packaging vector (2.5mg) into
subconﬂuent 100mm plate of 293FTcells using Fugene 6 (Roche). The
viral particles were collected at 48 and 72h post-transfection, ﬁltered
and concentrated by ultracentrifugation in Beckman SW28 rotor at
25000rpm for 1.5h 5 10
6 ST486 cells were transduced with the viral
particlesinthepresenceof8mg/mlpolybreneandcentrifugingat450g
for 1.5h.
Immunoblot analysis
For immunoblotting, whole-cell lysates were prepared from ST486
cells by using RIPA buffer (Teknova) with protease inhibitor cocktail
(Roche). Proteins were fractionated by SDS–PAGE and analyzed by
standard immunoblotting procedures using the following antibodies:
anti-FOXM1 (sc-502; Santa Cruz), anti-MYB (sc-517, Santa Cruz),
anti-MCM3 (559543, BD Pharmingen), anti-BUBR1 (ab4637, Abcam),
anti-AURKA (gift from Dr PT Stukenberg), anti-XBubR1 (gift from
Dr Y Mao), and anti-GAPDH (sc-32233; Santa Cruz).
Co-immunoprecipitation
Whole-cell lysates of 40 10
6 Ramos cells were prepared by using cell
lysis buffer (50mM Tris–HCl pH 8.1, 150mM NaCl and 0.5% NP-40)
with protease inhibitor cocktail.The lysatewas incubated overnight at
41C with mouse IgG or anti-MCM3 antibody (M038-3, MBL Intl),
followed by incubation in protein-G agarose beads (17-0618, Amer-
sham) for 2 hours. The beads were washed in buffer (20mM Tris–HCl
pH 8.1, 150mM NaCl, 10% glycerol, 0.2% NP-40 and 1mM EDTA) for
four times and incubated in SDS-loading buffer at 1001C for 10min.
Similarly, cell-free extract (LSS) was prepared from unfertilized
Xenopus eggs as described earlier(Smythe and Newport, 1991). Co-
IPs were performed by incubating extracts with anti-XMCM6
antibodies as described earlier (Ying and Gautier, 2005)) or control
antibodies (Rabbit IgG, Sigma) for 30min at 41C, followed by addition
of Protein A Sepharose beads (GE Healthcare) for 1h at 41C. Beads
were washed with ELB-0.2%NP-40 and ELB-0.5MNaCl, then boiled to
release bound proteins. Proteins were fractionated by SDS–PAGE and
analyzed by standard immunoblotting procedures.
Indirect immunoﬂuorescence
Ramos cells were ﬁxed in 10% formalin for 20min and post-ﬁxed in
ice-cold100%methanolfor20min.Cellswerethenblockedin5%BSA
for 1h and incubated with anti-MCM3 (559543, BD Pharmingen) and
anti-BUBR1 (ab4637, Abcam) or anti-MCM3, and anti-AURKA
(ab13824, Abcam) antibody for 2h at room temperature. The cells
were washed three times in PBS with 0.01% Tween-20 followed by
incubation with biotinylated goat anti-mouse IgG for 30min. It was
then incubated with FITC-conjugated goat anti-rabbit antibody and
Cy3-conjugated Streptavidin antibody (Jackson ImmunoResearch) for
30min. Stained cells were acquired at  100 magniﬁcation in LSM510
Multiphoton confocal microscope (Zeiss).
Figure 6 MCM3 and MCM6 interact with BUBR1 and AURKA. (A) MCM3 co-immunoprecipitates with BUBR1 and AURKA. Cell lysates of Ramos cell line were
immunoprecipitated with control IgG or anti-MCM3 antibodies and probed with anti-BUBR1 and anti-AURKA antibodies. (B) MCM6 binds to BUBR1 and AURKA in
Xenopus cell-free extracts. Interphase extracts from Xenopus cytosolic fraction were immunoprecipitated with anti-XMCM6 or control IgG antibodies and probed with
anti-XMCM6, anti-XBUBR1, and anti-XAURKA antibodies. (C) Co-localization of MCM3 with BUBR1 and AURKA in Ramos cells shown by confocal dual-color indirect
immunoﬂuorescence with (a) anti-MCM3 and anti-BUBR1 antibodies or (b) anti-MCM3 and anti-AURKA antibodies. DNA was stained with DAPI. Data shown are
representative of one of three independent experiments.
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Total RNA extracts was extracted with Trizol (Invitrogen) and puriﬁed
using RNeasy kit (Qiagen). For qPCR, cDNA was prepared from the
total RNA extract by using Reverse Transcriptase kit (Qiagen), and the
amount of each gene was determined by using SYBR Green (Qiagen)
on an Applied Biosystems 7300 thermal cycler. The reactions were run
in duplicate, and the number of copies of each gene was normalized to
the housekeeping gene GAPDH. For microarray analysis, total RNA
was ampliﬁed and converted into labeled double-stranded cDNA by
reverse transcription using Superscript II reverse transcriptase
(Invitrogen) and poly-dT oligonucleotide containing T7 RNA poly-
merase initiation site. Biotinylated cRNA was generated from the
double-stranded cDNA by using the one-cycle cDNA synthesis
protocol (Affymetrix, 701025 Rev.6). A measure of 15mg of fragmented
cRNA was hybridized to HG-U95Av2 microarrays (Affymetrix). For
oligonucleotide sequences, see Supplementary Table IX. GEPs were
normalized using a modiﬁed GC robust multiarray average (Lim et al,
2007) and differential expression was assessed by t-test (Supplemen-
tary Table V). GEO accession number is GSE17172.
Quantitative chromatin IP
Promoter sequences of the target genes 2kb upstream and 2kb
downstream of the transcription start site were retrieved by using
UCSC Golden Path database (Build35, May 2004) (Karolchik et al,
2008). We identiﬁed sites, as given by TRANSFAC, in 4kb promoters
using a scoring threshold corresponding to 0.9 speciﬁcity across all
knownpromoters(Smithet al,2007).ChIPanalysis wasdoneinST486
cell line by following the protocol described in the literature (Frank
et al, 2001). In brief, the protein–DNA complexes were cross-linked
usingformaldehyde,followedbyIPwithanti-MYB(mixtureofsc-7874
and sc-517 (Santa Cruz)), FOXM1 (sc-502, Santa Cruz), or Rabbit IgG.
The samples were reverse cross-linked and DNA was puriﬁed by
phenol-chloroform extraction. DNA pellet resuspended in 30mlo f
water, and the total input chromatin taken before IP was diluted in
150ml of water. A measure of 3ml of the DNA samples were taken and
binding of the TFs to the targets was determined by qPCR using the
primers designed to contain the putative-binding sites. For oligonu-
cleotide sequences, see Supplementary Table X.
Apoptotic analysis
The number of apoptotic and dead cells were determined by using the
Annexin V-FITC Apoptosis Kit (BD Pharmingen) according to the
manufacturer’s instructions. Samples were analyzed by using FACS
Calibur (Becton Dickinson).
Proliferation assay
The number of proliferating cells was determined by using the BrdU
Cell Proliferation Assay (Calbiochem) according to the manufacturer’s
protocol.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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